about
Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer ChemotherapygammaH2AX foci form preferentially in euchromatin after ionising-radiation.The human mitochondrial NADH: ubiquinone oxidoreductase 51-kDa subunit maps adjacent to the glutathione S-transferase P1-1 gene on chromosome 11q13.E4BP4/NFIL3, a PAR-related bZIP factor with many roles.Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatinComposite cis-acting epigenetic switches in eukaryotes: lessons from Drosophila Fab-7 for the Igf2-H19 imprinted domain.Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha.An overview of the visualisation and quantitation of low and high MW DNA adducts using the trapped in agarose DNA immunostaining (TARDIS) assay.Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents.Glutathione transferase pi its minimal promoter and downstream cis-acting element.Genome-wide ChIP-seq analysis of human TOP2B occupancy in MCF7 breast cancer epithelial cells.Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II.Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exons.The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1.NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.Topoisomerase II Chromatin Immunoprecipitation.The gene and pseudogenes of Cbx3/mHP1 gamma.Visualization and Quantification of Topoisomerase-DNA Covalent Complexes Using the Trapped in Agarose Immunostaining (TARDIS) Assay.Self-association of chromo domain peptides.Nuclear distribution of human DNA topoisomerase IIbeta: a nuclear targeting signal resides in the 116-residue C-terminal tail.Differential selection of acridine resistance mutations in human DNA topoisomerase IIbeta is dependent on the acridine structureTOP2B: The First Thirty YearsEffect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA ComplexesMonoclonal antibodies against plant proteins recognise animal intermediate filamentsMolecular biology of glutathione transferasesThe Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II PoisonIntercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations
P50
Q28818421-02C2D9EE-DC48-451D-A537-261CBFDFDBDDQ33303665-D1A212CA-E8A9-4A7E-AA5B-4226AAC8C6C6Q34295815-9E7B3252-A224-4890-BC6C-952797F3527FQ34974415-582BE21F-D1E9-4C46-B223-2851655F39C3Q35015901-82D82129-6C0F-4A30-8192-F8ADC66B2959Q35118127-9735949C-6848-4F49-B5F0-174332D0D26AQ35401202-0D7EF7FB-F557-4A1D-B3BD-95441921A52EQ37808574-CB34C030-59F7-4C43-AA3E-CED033D54935Q38029323-1AD6C234-4A7C-4BB9-B921-3EF539A09C8CQ38335642-DF0FBA7B-5B9F-4B1B-A880-30EB71C25754Q38456475-649502DE-FC79-4F8A-8CA8-1662F8923428Q38801085-7AED391D-EE0C-48C2-807D-EDA32F45CA9BQ38957719-6E957726-406A-4938-ADAB-4793E299AE71Q39044567-2E01CD3F-A842-4696-A23F-0571BFCA43F3Q40075000-06B68228-A087-4758-812B-6BC19AA250A7Q46535643-4E5B27FC-8874-4A42-89A6-BC44230088BAQ47362326-176EAE77-41E9-4C93-9FEE-8FB0DAE8E9B3Q48326328-D890F936-5998-4969-88F8-78702C296F9DQ49607557-8C85CA15-2179-442F-82C0-619E296B8B7BQ52552439-F09B30E9-4929-4EE0-AD77-F21901084397Q55067961-15E69251-0048-416E-B69D-083C6C992CABQ56898431-6A5651C5-152F-4112-8BA6-9719F09BBC25Q58738913-D0A9C23A-505D-4916-8EDD-F7B92C4C87F3Q64389240-2336A493-562E-49D1-853D-34AAE528B124Q69012422-910E71B7-8D98-440D-A1F5-63DB1E6EB994Q69445166-604FAFDD-31F9-4042-91C3-2968E6A3796FQ90083269-4E2C8CFB-00A5-4314-8535-E756A48B56D7Q92533787-1C988CA6-CB15-49A5-86F3-C9D68F3AF035
P50
description
researcher ORCID ID = 0000-0002-8606-0447
@en
name
Ian G Cowell
@ast
Ian G Cowell
@en
Ian G Cowell
@es
Ian G Cowell
@nl
type
label
Ian G Cowell
@ast
Ian G Cowell
@en
Ian G Cowell
@es
Ian G Cowell
@nl
prefLabel
Ian G Cowell
@ast
Ian G Cowell
@en
Ian G Cowell
@es
Ian G Cowell
@nl
P1153
6603929376
P31
P496
0000-0002-8606-0447